October 11, 2018
SALT LAKE CITY, UT / ACCESSWIRE / October 11, 2018 / ProLung, Inc. ("ProLung" or the "Company") today released a letter to its shareholders with an important intellectual property and regulatory update. ProLung® is pleased to announce receipt of a new Notice of Allowance for our proprietary
October 02, 2018
SALT LAKE CITY, UT / ACCESSWIRE / October 2, 2018 / ProLung, Inc. ("ProLung" or the "Company") today disclosed a letter to its stockholders from former ProLung® Board Members Clark Campbell, William Fresh, Rich McKeown, Tim Treu and Dennis Tulane. The complete text of the letter is set forth below.
October 01, 2018
Board In Fact Leads Substantially in the Vote Tally ProLung Urges Shareholders to Continue to Sign and Submit the GOLD Card SALT LAKE CITY, UT / ACCESSWIRE / October 1, 2018 / The board of directors (the “Board”) of ProLung, Inc. (“ProLung” or the “Company”) today issued the following statement in
September 19, 2018
Additions Bring Extensive Operating Experience in Medical Technology and Diagnostics as well as Repeated Success with the FDA Approval Process SALT LAKE CITY, UT / ACCESSWIRE / September 19, 2018 / ProLung, Inc. (''ProLung'' or the ''Company'') today announced the appointment of Rob Farnsworth and
September 13, 2018
Dear ProLung Shareholders and Colleagues, I have accepted the position of interim CEO of ProLung, Inc. It is an honor to be given the opportunity to work with each of you and to lead ProLung in its next
September 13, 2018
Jared Bauer Named Interim CEO and Details Seven-Point Go-Forward Strategy SALT LAKE CITY, UT / ACCESSWIRE / September 13, 2018 / ProLung, Inc. ("ProLung" or the "Company") today announced the Company is taking significant steps to better align its product, regulatory, marketing, and consulting
August 27, 2018
SALT LAKE CITY, UT / ACCESSWIRE / August 27, 2018 / ProLung, Inc. (''ProLung'' or the ''Company'') today released a communication urging stockholders to fill out and return the GOLD consent revocation card from the Company, which they can use to decline or revoke consent to the actions proposed by
August 15, 2018
SALT LAKE CITY, UT / ACCESSWIRE / August 15, 2018 / ProLung, Inc. (“ProLung” or the “Company”) today released a communication urging stockholders not to respond to the consent solicitation by Steven C. Eror. The Company announced that stockholders will soon receive consent revocation materials and
June 18, 2018
SALT LAKE CITY, UT / ACCESSWIRE / June 18, 2018 / Corporate Vision announced that ProLung, Inc. ("ProLung" or the "Company") is their "2018's Most Innovative Predictive Analytics Award - USA" winner. Andy Robertson, Chief Marketing Officer of ProLung® stated, "Earning this innovation award is
May 30, 2018
ProLung is very excited to have our Company and product, the ProLung Test™, featured in Pharma Tech Outlook’s May 2018 Special Issue on Pharma Analytics. Named as a Top Ten Analytics Solution Provider in 2018, we are eager to continue preparing for commercialization and pursuing a bold strategy to
